Cargando…

Diagnostic sensitivity for invasive cervical carcinoma of high risk HPV tests performed on SurePath™ liquid-based pap specimens

Detalles Bibliográficos
Autor principal:	Nance, Keith V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621606/ https://www.ncbi.nlm.nih.gov/pubmed/23580399 http://dx.doi.org/10.2147/DHPS.S44258

Ejemplares similares

Detection of cervical precancerous lesions with Aptima HPV assays using SurePath preservative fluid specimens
por: Chernesky, Max, et al.
Publicado: (2017)

Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility
por: Day, Sarah J, et al.
Publicado: (2004)

Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II(+) detection rates
por: Rozemeijer, Kirsten, et al.
Publicado: (2015)

Cytological Evaluation and REBA HPV-ID HPV Testing of Newly Developed Liquid-Based Cytology, EASYPREP: Comparison with SurePath
por: Lee, Youn Soo, et al.
Publicado: (2013)

The effect of the small amount of formaldehyde in the SurePath liquid when establishing protocols for immunocytochemistry
por: Bjønness-Jacobsen, Ellen Cathrine, et al.
Publicado: (2016)

Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
por: Rebolj, Matejka, et al.
Publicado: (2015)

Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category? A study on SurePath™ specimens with review of literature
por: Shidham, Vinod B, et al.
Publicado: (2007)

The BD Onclarity HPV Assay on Samples Collected in SurePath Medium Meets the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening
por: Ejegod, Ditte, et al.
Publicado: (2016)

Clinical and analytical performance of the BD Onclarity™ HPV assay for detection of CIN2+ lesions on SurePath samples
por: Ejegod, Ditte Møller, et al.
Publicado: (2016)

Impact of SurePath(®) liquid-based preparation in cytological analysis of peritoneal washing in practice of gynecologic oncology
por: Tyagi, Ruchita, et al.
Publicado: (2017)

Tubercular granulomas in Bronchoalveolar lavage fluid in SurePath liquid-based cytology smears: An enigmatic finding
por: Badyal, Rama Kumari, et al.
Publicado: (2021)

Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests
por: Tardif, Keith D., et al.
Publicado: (2016)

Prevalence of Human Papillomavirus in 5,072 Consecutive Cervical SurePath Samples Evaluated with the Roche Cobas HPV Real-Time PCR Assay
por: Preisler, Sarah, et al.
Publicado: (2013)

Comparison of the Cepheid Xpert HPV test and the HC2 High-Risk HPV DNA Test for detection of high-risk HPV infection in cervical smear samples in SurePath preservative fluid
por: Rabaan, Ali A., et al.
Publicado: (2018)

APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database
por: Khader, Samer N., et al.
Publicado: (2010)

A comparative analysis of conventional and SurePath liquid-based cervicovaginal cytology: A study of 140 cases
por: Sharma, Jyotsna, et al.
Publicado: (2016)

Clinical and Analytical Performance of the BD Onclarity HPV Assay with SurePath Screening Samples from the Danish Cervical Screening Program Using the VALGENT Framework
por: Bonde, Jesper Hansen, et al.
Publicado: (2020)

Diagnostic Utility and Efficacy of Conventional Versus SurePath® Liquid-based Cytology in Head and Neck Pathology: A Study in an Indian Tertiary Care Hospital
por: Sharma, Sonam, et al.
Publicado: (2018)

Can an inadequate cervical cytology sample in ThinPrep be converted to a satisfactory sample by processing it with a SurePath preparation?
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2017)

Combining Endometrium Sampling Device and SurePath Preparation to Screen for Endometrial Carcinoma: A Validation Study
por: Wen, Jia, et al.
Publicado: (2015)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Unsatisfactory rates vary between cervical cytology samples prepared using ThinPrep and SurePath platforms: a review and meta-analysis
por: Fontaine, Daniel, et al.
Publicado: (2012)

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4
por: Cuzick, Jack, et al.
Publicado: (2016)

Collection of the BD SurePath Pap Test with a broom device plus endocervical brush improves disease detection when compared to the broom device alone or the spatula plus endocervical brush combination
por: Davis-Devine, Sharon, et al.
Publicado: (2008)

Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
por: Rozemeijer, Kirsten, et al.
Publicado: (2017)

A prospective randomized noninferiority trial comparing conventional smears and SurePath(TM) liquid-based cytology in endoscopic ultrasound-guided sampling of esophageal, gastric, and duodenal lesions
por: Jun, Jae Chang, et al.
Publicado: (2023)

Immunocytochemical expression of Ki-67/p16 in normal, atypical, and neoplastic cells in urine cytology using BD SurePath™ as preparation method
por: Østbye, Kirsten Margrethe, et al.
Publicado: (2019)

Clinical Validation of the Onclarity Assay After Assay Migration to the High-Throughput COR Instrument Using SurePath Screening Samples From the Danish Cervical Cancer Screening Program
por: Ejegod, Ditte Møller, et al.
Publicado: (2021)

Evaluation of the SureX HPV genotyping test for the detection of high-risk HPV in cervical cancer screening
por: Wei, Baojun, et al.
Publicado: (2020)

Comparison of the Cobas 4800 HPV and HPV 9G DNA Chip Tests for Detection of High-Risk Human Papillomavirus in Cervical Specimens of Women with Consecutive Positive HPV Tests But Negative Pap Smears
por: Jun, Sun-Young, et al.
Publicado: (2015)

Broom versus broom-and-brush: A comparison of Surepath(®) liquid-based Papanicolaou test (LBPT) collection devices
por: Ngae, Min Yi, et al.
Publicado: (2009)

Evaluation of the Performance of CinTec® PLUS in SurePathTM Liquid-Based Cervico-Vaginal Samples
por: Sharma, Pooja, et al.
Publicado: (2021)

Vaginal Infections of Albanian women Infected with HPV and their impact in intraepithelial cervical lesions evidenced by Pap test
por: Kone, Elsa S, et al.
Publicado: (2017)

The Impact of Video-Based Educational Interventions on Cervical Cancer, Pap Smear and HPV Vaccines
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2021)

The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
por: Volpini, Lays Paula Bondi, et al.
Publicado: (2017)

Repeated Positive Cervical HPV Testing and Absent or Minor Cytology Abnormality at Pap Smear. What is the Next Step?
por: Caeiro, Vitor, et al.
Publicado: (2021)

Correction: The high prevalence of HPV and HPV16 European variants in cervical and anal samples of HIV-seropositive women with normal Pap test results
Publicado: (2017)

The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13 842 women
por: Bigras, G, et al.
Publicado: (2005)

Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling
por: Shin, Hye Young, et al.
Publicado: (2019)

Comparison of PAP smear and liquid based cytology as a screening method for cervical carcinoma
por: Khakwani, Mehnaz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ptpuvk2rs5lsp4af1mhmq3mnl4